Neuralink, the brain technology firm led by Elon Musk, has been cited by the Food and Drug Administration (FDA) for “objectionable conditions…
By Rachael Levy (Reuters) – An animal testing laboratory at Elon Musk’s Neuralink brain technology company was found to have “objectionable conditions…
PARIS (Reuters) – The fall of the government leaves France without a clear path toward reducing its budgetary deficit, credit rating agency…
By Promit Mukherjee OTTAWA (Reuters) – Canada’s fiscal targets over the next few years will be tougher to achieve as a promised…
By Howard Schneider WASHINGTON (Reuters) – In another era, agreement among analysts from leading left, center, and right-leaning think tanks over a…
Bank of England Governor Andrew Bailey has indicated that a series of gradual interest rate cuts is likely to occur over the…
The Organization for Economic Cooperation and Development (OECD) has revised its economic growth forecast for Germany, predicting a slower rate of 0.7%…
By Nora Eckert DETROIT (Reuters) -General Motors told shareholders on Wednesday that it would record two non-cash charges totaling more than $5…
In November, the euro zone experienced a sharp decline in business activity, with a significant contraction in the services sector adding to…
By Douglas Gillison (Reuters) – The sale of Americans’ private information by “data brokers” to scammers, foreign adversaries, abusive domestic partners and…
